-
-
-
-
-
-
-
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Applied Genetic Technologies (AGTC) Reports Q3 Loss of $0.40/sh
-
-
-
-
-
-
-
AGTC Provides Trial Design Update for its Phase 2/3 XLRP Clinical Trial, New Data on XLRP Higher Dose Group and Financial Results for the Fourth Quarter and Year Ended June 30, 2020
-
-
-
-
-
-
-
Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program
-
-
-
-
-
-
-
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2019
-
-
-
-
-
-
-
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 7, 2019
-
-
-
-
-
-
-
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

